These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24848702)

  • 1. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Shah M; Rajagopalan S; Xu L; Voshavar C; Shurubor Y; Beal F; Andersen JK; Dutta AK
    J Neurochem; 2014 Oct; 131(1):74-85. PubMed ID: 24848702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
    Voshavar C; Shah M; Xu L; Dutta AK
    Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
    Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
    Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways.
    He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J
    Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP
    Luo D; Zhao J; Cheng Y; Lee SM; Rong J
    Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-512, a novel dopamine D
    Lindenbach D; Das B; Conti MM; Meadows SM; Dutta AK; Bishop C
    Br J Pharmacol; 2017 Sep; 174(18):3058-3071. PubMed ID: 28667675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
    Ghosh A; Langley MR; Harischandra DS; Neal ML; Jin H; Anantharam V; Joseph J; Brenza T; Narasimhan B; Kanthasamy A; Kalyanaraman B; Kanthasamy AG
    J Neuroimmune Pharmacol; 2016 Jun; 11(2):259-78. PubMed ID: 26838361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
    Manouchehrabadi M; Farhadi M; Azizi Z; Torkaman-Boutorabi A
    Neurotox Res; 2020 Jan; 37(1):156-170. PubMed ID: 31364033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents.
    Luo D; Shi Y; Wang J; Lin Q; Sun Y; Ye K; Yan Q; Zhang H
    Neurosci Lett; 2016 May; 620():43-9. PubMed ID: 27019033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's disease animal model.
    Santra S; Xu L; Shah M; Johnson M; Dutta A
    ACS Chem Neurosci; 2013 Oct; 4(10):1382-92. PubMed ID: 23906010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.